136 related articles for article (PubMed ID: 15645192)
1. [Pharmacogenetics: Important aspects for dermatology].
Merk HF
Hautarzt; 2005 Jan; 56(1):44-7. PubMed ID: 15645192
[TBL] [Abstract][Full Text] [Related]
2. Reinstatement of dapsone following hypersensitivity.
Labandeira J; Toribio J
Acta Derm Venereol; 2003; 83(4):314-5. PubMed ID: 12926815
[No Abstract] [Full Text] [Related]
3. Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests.
Khan DA
J Allergy Clin Immunol; 2016 Oct; 138(4):943-955. PubMed ID: 27720019
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics in dermatology: from susceptibility genes to personalized therapy.
Pincelli C; Pignatti M; Borroni RG
Exp Dermatol; 2009 Apr; 18(4):337-49. PubMed ID: 19348000
[TBL] [Abstract][Full Text] [Related]
5. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenetics].
Merk HF
Hautarzt; 2010 Aug; 61(8):650-3. PubMed ID: 20644905
[TBL] [Abstract][Full Text] [Related]
7. Role of dermatology in pharmacogenomics: drug-induced skin injury.
Borroni RG
Pharmacogenomics; 2015; 16(4):401-12. PubMed ID: 25823788
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics in dermatology: a patient-centered update.
Comfere NI; Ikediobi ON; Peters MS; el-Azhary RA; Gibson LE
Int J Dermatol; 2013 Aug; 52(8):1005-12. PubMed ID: 23786543
[TBL] [Abstract][Full Text] [Related]
9. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.
Aghdaie MH; Azarpira N; Geramizadeh B; Sagheb M; Darai M; Rahsaz M; Malekhoseini SA
Exp Clin Transplant; 2011 Aug; 9(4):241-6. PubMed ID: 21819368
[TBL] [Abstract][Full Text] [Related]
10. The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015.
Dodiuk-Gad RP; Olteanu C; Chung WH; Shear NH
Drug Saf; 2016 Mar; 39(3):271-6. PubMed ID: 26798049
[No Abstract] [Full Text] [Related]
11. An update on pediatric cutaneous drug eruptions.
Song JE; Sidbury R
Clin Dermatol; 2014; 32(4):516-23. PubMed ID: 25017462
[TBL] [Abstract][Full Text] [Related]
12. Severe dapsone hypersensitivity syndrome.
Sener O; Doganci L; Safali M; Besirbellioglu B; Bulucu F; Pahsa A
J Investig Allergol Clin Immunol; 2006; 16(4):268-70. PubMed ID: 16889287
[TBL] [Abstract][Full Text] [Related]
13. A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study.
Newman WG; Payne K; Tricker K; Roberts SA; Fargher E; Pushpakom S; Alder JE; Sidgwick GP; Payne D; Elliott RA; Heise M; Elles R; Ramsden SC; Andrews J; Houston JB; Qasim F; Shaffer J; Griffiths CE; Ray DW; Bruce I; Ollier WE;
Pharmacogenomics; 2011 Jun; 12(6):815-26. PubMed ID: 21692613
[TBL] [Abstract][Full Text] [Related]
14. [Molecular biology and dermatology research].
Orozco Topete R
Rev Invest Clin; 2003; 55(2):168-71. PubMed ID: 12827921
[No Abstract] [Full Text] [Related]
15. [Pharmacogenomics in dermatology].
Harr T; Itin PH
J Dtsch Dermatol Ges; 2005 Mar; 3(3):214-21; quiz 222, 224. PubMed ID: 16372817
[No Abstract] [Full Text] [Related]
16. [Future direction of pharmacogenomics: identification of genes associated with risk of adverse drug reactions using genome-wide association study].
Mushiroda T
Rinsho Byori; 2014 Jan; 62(1):83-8. PubMed ID: 24724431
[TBL] [Abstract][Full Text] [Related]
17. [Basophil activation tests in the diagnosis of drug reactions].
Erdmann SM; Ventocilla S; Moll-Slodowy S; Sauer I; Merk HF
Hautarzt; 2005 Jan; 56(1):38-43. PubMed ID: 15625602
[TBL] [Abstract][Full Text] [Related]
18. [Cutaneous drug reactions: pharmacogenetic news].
Buffard V; Roujeau JC
Arch Pediatr; 2004 May; 11(5):489-92. PubMed ID: 15135444
[TBL] [Abstract][Full Text] [Related]
19. Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase.
Perri D; Cole DE; Friedman O; Piliotis E; Mintz S; Adhikari NK
Eur Respir J; 2007 Nov; 30(5):1014-7. PubMed ID: 17978158
[TBL] [Abstract][Full Text] [Related]
20. Coexisting linear and disseminated drug eruption: a clinical clue to the understanding of the genetic basis of drug eruptions.
Happle R; Effendy I
Eur J Dermatol; 2001; 11(2):89. PubMed ID: 11275799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
